438 related articles for article (PubMed ID: 11424588)
1. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
Fülöp V; Végh G; Doszpod J
Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
4. Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitro.
Steller MA; Mok SC; Yeh J; Fulop V; Anderson DJ; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):209-16. PubMed ID: 8035376
[TBL] [Abstract][Full Text] [Related]
5. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta.
Singh M; Kindelberger D; Nagymanyoki Z; Ng SW; Quick CM; Yamamoto H; Fichorova R; Fulop V; Berkowitz RS
J Reprod Med; 2012; 57(5-6):197-203. PubMed ID: 22696812
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
Shih IM; Kurman RJ
Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
[TBL] [Abstract][Full Text] [Related]
9. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
10. Biology of human trophoblast.
Mochizuki M; Maruo T; Matsuo H; Samoto T; Ishihara N
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S21-8. PubMed ID: 9833611
[TBL] [Abstract][Full Text] [Related]
11. Production of granulocyte-macrophage colony-stimulating factor by human trophoblast cells and by decidual large granular lymphocytes.
Jokhi PP; King A; Loke YW
Hum Reprod; 1994 Sep; 9(9):1660-9. PubMed ID: 7530725
[TBL] [Abstract][Full Text] [Related]
12. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ
Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease.
Cameron B; Gown AM; Tamimi HK
Am J Obstet Gynecol; 1994 Jun; 170(6):1616-21; discussion 1621-2. PubMed ID: 7911272
[TBL] [Abstract][Full Text] [Related]
14. Expression of TGF-beta signaling proteins in normal placenta and gestational trophoblastic disease.
Xuan YH; Choi YL; Shin YK; Ahn GH; Kim KH; Kim WJ; Lee HC; Kim SH
Histol Histopathol; 2007 Mar; 22(3):227-34. PubMed ID: 17163397
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-erbB2 in gestational trophoblastic disease and its clinical significance.
Wang Y; Cao Y; Sun Y
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):123-5. PubMed ID: 12658752
[TBL] [Abstract][Full Text] [Related]
18. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
19. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of a tumor necrosis factor receptor-related transcript in gestational trophoblastic diseases in women.
Dumur CI; Koritschoner NP; Flury A; Panzetta-Dutari G; Bocco JL; Patrito LC
Biol Reprod; 1998 Sep; 59(3):621-5. PubMed ID: 9716562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
